Dementia researchers have been busy with new risk factors identified by The Lancet, the approval of dementia-slowing drugs, and the exploration of menstrual blood containing stem cells for neurodegenerative illnesses. Dr. Karan Rajan discusses the regenerative abilities of menstrual blood-derived stem cells, which have shown promising results in dementia studies in mice. However, research is still in early stages, with uncertainty around the best collection methods and the need for human trials to confirm effectiveness.
Full Article
Loading PerspectiveSplit analysis...






